戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 est short-term risk (ie, older age, abnormal exercise test).
2  Fitness was measured by a maximal treadmill exercise test.
3 ty risk in individuals undergoing a clinical exercise test.
4 antly improves the diagnostic performance of exercise test.
5 ise capacity, was used as the outcome of the exercise test.
6  during at least 1 mental test or during the exercise test.
7 ith methacholine challenge being superior to exercise test.
8 ients with asymptomatic severe AS and normal exercise test.
9 children completed a symptom-limited maximal exercise test.
10 tan procedure and subsequent cardiopulmonary exercise test.
11 ases who had negative results in the wheat + exercise test.
12 on, and CRF assessed using a treadmill-based exercise test.
13    CRF was quantified by a maximal treadmill exercise test.
14  symptom-limited Naughton protocol treadmill exercise tests.
15 rpreting patterns of change during the short exercise tests.
16 965 patients undergoing clinically indicated exercise testing.
17 urvivors of acute MI and patients undergoing exercise testing.
18 , echocardiography, and invasive hemodynamic exercise testing.
19  quantified as duration of maximal treadmill exercise testing.
20 of their maximum-predicted heart rate during exercise testing.
21  stress echocardiography and cardiopulmonary exercise testing.
22 imum upright cycle ergometry cardiopulmonary exercise testing.
23 nance for ventricular function and metabolic exercise testing.
24 ainide or placebo) for 3 months, followed by exercise testing.
25 ar magnetic resonance, echocardiography, and exercise testing.
26 ecific quality of life instruments and short exercise testing.
27  dietary intake determined in the 4 d before exercise testing.
28 the incidence of HF in veterans referred for exercise testing.
29 ere studied with incremental cardiopulmonary exercise testing.
30 ting, pharmacologic interventions, and acute exercise testing.
31 ebo or flecainide) for 3 months, followed by exercise testing.
32 emodynamics underwent supine lower extremity exercise testing.
33 pliance and arterial elastance), and maximal exercise testing.
34 ts, 6-min walking tests, and cardiopulmonary exercise testing.
35 unction who are referred for cardiopulmonary exercise testing.
36 st Physicians (ATS/ACCP) recommendations for exercise testing.
37 lantation) for 2 years after cardiopulmonary exercise testing.
38 ith partial LVAD support and cardiopulmonary exercise testing.
39 CO2 slope was determined via cardiopulmonary exercise testing.
40 e twice the risk as comparable patients with exercise testing.
41 iated with maximal output on cardiopulmonary exercise testing.
42 aire; a subgroup of 251 women also underwent exercise testing.
43 derwent clinically indicated cardiopulmonary exercise testing.
44 hort comprising patients undergoing clinical exercise testing.
45 0.005) but no relations with cardiopulmonary exercise testing.
46 n=10) underwent MR-augmented cardiopulmonary exercise testing.
47 nance imaging (CMRI), Holter monitoring, and exercise testing.
48 hic cardiomyopathy underwent cardiopulmonary exercise testing.
49  of 31 included patients performed a maximal exercise test (15 boys, 11.6 +/- 2.9 years, weight, 40.9
50  After 27 +/- 15 months from the most recent exercise test, 19 patients died or were re-heart transpl
51 clinical examination, ECG, echocardiography, exercise testing, 24h Holter ECG, and cardiac magnetic r
52 3 months postoperatively and cardiopulmonary exercise testing 3 months postoperatively.
53 in 134 patients referred for cardiopulmonary exercise testing: 79 with HFpEF and 55 controls.
54                             During a hypoxia exercise test, a dose-dependent hypoxia-induced decrease
55  and after cooling were <20%, a repeat short exercise test after rewarming was useful in patients wit
56 ation was significantly higher than that for exercise test alone (0.84 versus 0.78; P=0.007).
57 failure (HF), during maximal cardiopulmonary exercise test, anaerobic threshold (AT) is not always id
58  ejection fraction < or =0.40 underwent MTWA exercise tests, analyzed with the spectral method and cl
59     All patients underwent a cardiopulmonary exercise test and a phosphorus magnetic resonance spectr
60 l participants performed a maximal treadmill exercise test and completed a follow-up health survey in
61 Between 2001 and 2009, using cardiopulmonary exercise test and echocardiography, we studied 82 childr
62  metabolic equivalents (MET) achieved during exercise test and eight categories based on fitness stat
63  receiver operating characteristic curve for exercise test and global longitudinal peak systolic stra
64 ic equivalents [METs]) and were compared for exercise test and imaging outcomes, particularly the pre
65 gated the association between HR response to exercise testing and age with prognosis in 5437 asymptom
66 functional outcomes included cardiopulmonary exercise testing and arterial compliance.
67       All subjects underwent cardiopulmonary exercise testing and cardiac magnetic resonance imaging,
68           Patients underwent cardiopulmonary exercise testing and echocardiography to assess systolic
69 ventional methods, including cardiopulmonary exercise testing and echocardiography.
70                                              Exercise testing and EF were assessed 4 and 12 weeks aft
71                       Participants underwent exercise testing and measurement of left ventricular EF
72 CHF as assessed by symptom-limited treadmill exercise testing and measurement of peak oxygen consumpt
73 l consequences of valve obstruction, such as exercise testing and serum brain natriuretic peptide lev
74 antially more common (112 of 122 [92%]) than exercise testing and stress echocardiography (21 of 122
75           Epinephrine infusion combined with exercise testing and targeted genetic testing is recomme
76 nce in selected patients with early-positive exercise testing and those with frequent angina.
77 ow more reliable interpretation of the short exercise tests and aid accurate DNA-based diagnosis.
78 cteristics that are determined directly from exercise; testing and all-cause mortality during a media
79            Fitness was assessed by a maximal exercise test, and adiposity was assessed by body mass i
80  multivariable adjustment for baseline data, exercise test, and conventional echocardiography (odds r
81 rols using needle electromyography, the long exercise test, and short exercise tests at room temperat
82 ine healthy participants performed a maximal-exercise test, and two 30 min sessions of semi-recumbent
83 ne Doppler echocardiography, cardiopulmonary exercise testing, and cardiac MRI.
84 diography, echocardiography, cardiopulmonary exercise testing, and cardiovascular magnetic resonance
85  resonance, a comprehensive biomarker panel, exercise testing, and clinical events over 6 months.
86 al data, ECG, laboratory and cardiopulmonary exercise testing, and echocardiography.
87            Echocardiography, cardiopulmonary exercise testing, and laboratory evaluation were perform
88 sectional study, extensive echocardiography, exercise testing, and NT-proBNP measurements were perfor
89 rial data on the clinical value of screening exercise testing are absent; that is, it is not known wh
90 ardiovascular magnetic resonance imaging and exercise testing are important in the risk assessment of
91                                  In the long exercise test, area decrements from pre-exercise baselin
92 ifferences in the normative data of the long exercise test argue for the use of appropriate ethnicall
93                                   The use of exercise testing as an objective assessment of cardiores
94 %) underwent symptom-limited cardiopulmonary exercise testing as part of routine management and were
95 ; age 60 +/- 10 years), undergoing a routine exercise test at the Veterans Affairs Medical Center, Wa
96 ean+/-SD, 71.4+/-5.0 years) who completed an exercise test at the Veterans Affairs Medical Centers in
97 sease who successfully completed a treadmill exercise test at the Veterans Affairs Medical Centers in
98 ssed by the Seattle Angina Questionnaire and exercise testing at 6 and 12 months.
99 ody weight per minute during cardiopulmonary exercise testing at 6 months.
100 ge, 33+/-13 years) underwent cardiopulmonary exercise testing at a single center over a period of 10
101 n consumption, measured with cardiopulmonary exercise testing at baseline and 8 and 24 weeks.
102 y aged 18-30 in 1985 who underwent treadmill exercise testing at baseline visit, and 2,735 participan
103 myography, the long exercise test, and short exercise tests at room temperature, after cooling, and r
104 otal of 1,326 persons went through a hypoxic exercise test before a sojourn above 4,000 m.
105           Patients underwent cardiopulmonary exercise testing before and after treatment.
106 nge 26-86 years) underwent cardiorespiratory exercise testing before major hepatobiliary surgery at a
107                             All completed an exercise test between 1986 and 2011 with no evidence of
108 formed a submaximal invasive cardiopulmonary exercise test between January 2013 and July 2014.
109 rcise capacity (peak VO2) on cardiopulmonary exercise testing, both measured at 12 months.
110               A wealth of data indicate that exercise testing can be used to assess and refine progno
111                 Conventional cardiopulmonary exercise testing can objectively measure exercise intole
112                       Use of the DASI before exercise testing can risk stratify symptomatic women and
113  workup, including ECG, signal averaged ECG, exercise testing, cardiac imaging, Holter-monitoring, an
114  or impaired performance on a low-technology exercise test, cardiopulmonary exercise testing should b
115                    Compared with traditional exercise tests, cardiopulmonary exercise testing (CPET)
116                        Using cardiopulmonary exercise testing, cardiovascular reserve was evaluated i
117  and were regularly tested (echocardiograms, exercise tests, catheterizations) with the pump at low s
118     Cardiac MRI, echocardiography, metabolic exercise testing, chest radiography, and hemodynamics be
119                              Cardiopulmonary exercise test combined with simultaneous exercise echoca
120    The aim of this study was to determine if exercise testing could expose a latent electrical substr
121                            A cardiopulmonary exercise test (CPET) with expired gas analysis was used
122 ult patients, the utility of cardiopulmonary exercise testing (CPET) in children as a prognostic tool
123 alyses concerning the use of cardiopulmonary exercise testing (CPET) in preoperative risk evaluation
124  traditional exercise tests, cardiopulmonary exercise testing (CPET) provides a thorough assessment o
125                              Cardiopulmonary exercise testing (CPET) was prospectively performed in 1
126                              Cardiopulmonary exercise test (CPX) responses are strong predictors of o
127 In the past several decades, cardiopulmonary exercise testing (CPX) has seen an exponential increase
128                              Cardiopulmonary exercise testing (CPX) with measurement of peak oxygen u
129 l, electrocardiographic, and cardiopulmonary exercise test data from 332 male professional soccer pla
130 health-related quality of life, imaging, and exercise testing data, we estimated incremental prognost
131                                              Exercise testing demonstrated significant improvement in
132 well either on a 6-minute walk or submaximal exercise testing despite increased right-to-left shuntin
133  in a subset of 572610 men with data from an exercise test did not reduce the associations.
134                                              Exercise testing, drug provocation, advanced cardiac ima
135 x-specific distribution of maximal treadmill exercise test duration.
136 9.5 years) who completed a maximal treadmill exercise test during the period from 1974 to 2001 and wh
137       We analyzed all children who underwent exercise testing during HT evaluation at our center betw
138 ger studies are needed to assess the role of exercise testing during HT evaluation in children with a
139                                              Exercise testing during HT evaluation in children with b
140 ticipants underwent baseline cardiopulmonary exercise testing, echocardiogram, biomarker assessment,
141 height, and weight underwent cardiopulmonary exercise testing, echocardiography including tissue-Dopp
142 ng serum biomarker analysis, cardiopulmonary exercise testing, echocardiography, and cardiac magnetic
143   Subjects were studied with cardiopulmonary exercise testing, echocardiography, and cardiac MRI.
144                                              Exercise testing, echocardiography, B-type natriuretic p
145                  Variables from standardized exercise testing, echocardiography, cardiac magnetic res
146                                              Exercise testing exposes a latent electrical substrate i
147 n, mean age 59 years) underwent a submaximal exercise test (first 2 stages of the Bruce protocol), ap
148 did a systematic review of studies of formal exercise testing for adults with cancer.
149 cted) who underwent invasive cardiopulmonary exercise testing for unexplained exertional intolerance.
150 d during maximal incremental cardiopulmonary exercise testing from 87 consecutive heart transplant as
151                              Cardiopulmonary exercise test, functional class, blood samples, and qual
152 cording to peak VO(2) during cardiopulmonary exercise testing (&gt;14, 10-14, and <10 mL/min per kg).
153 ion computed tomography (MPGS) compared with exercise test has not yet been properly evaluated.
154               An abnormal ECG during maximal exercise testing has been shown to be a powerful predict
155 lar survey, including a standardized bicycle exercise test in 1972 to 1975.
156 at rest and immediately post-cardiopulmonary exercise test in 207 patients (63 +/- 8 years of age) wi
157 rtery occlusion during the last minute of an exercise test in 76 dogs (from 2 independent studies) wi
158  sex, and risk factor, who were referred for exercise testing in an academic medical center.
159                  We give recommendations for exercise testing in clinical oncology research.
160  Appropriate, except for calcium scoring and exercise testing in intermediate and high-risk individua
161 on of dyspnea during bronchial challenge and exercise testing in obese patients with asthma and misdi
162 mortality, is difficult to assess by maximal exercise testing in older adults.
163               The results of cardiopulmonary exercise testing in patients with structural evidence of
164 nown whether a strategy of routine screening exercise testing in selected subjects reduces the risk f
165 pleted two symptom-limited incremental cycle exercise tests, in randomized order: unloaded control an
166 2 years; 52.2% male) underwent a mean of 2.7 exercise tests, in which 79 (3.7%) developed NSVT with e
167                              Cardiopulmonary exercise testing indices peak oxygen consumption, VE/Vco
168          The added discriminative ability of exercise test information and MPGS was assessed by net r
169 tory, echocardiographic, and cardiopulmonary exercise test investigations at study enrollment.
170  We have demonstrated that a cardiopulmonary exercise test is feasible in ambulatory children with di
171 ion imperative, but although cardiopulmonary exercise test is well established as a powerful tool in
172 gen consumption (peak VO2) <50% predicted on exercise testing is a class I indication for heart trans
173  (CRF) as assessed by formalized incremental exercise testing is an independent predictor of numerous
174                         Invasive hemodynamic exercise testing is commonly used in the evaluation of p
175                 MR-augmented cardiopulmonary exercise testing is feasible in both healthy children an
176                              Cardiopulmonary exercise testing is feasible in children with DCM and is
177                                              Exercise testing is more sensitive than saline loading t
178  standards for methods and data reporting in exercise testing is needed to ensure high-quality resear
179 ul in estimating fitness level when standard exercise testing is not feasible.
180                              Cardiopulmonary exercise testing is often used to evaluate exercise capa
181                                              Exercise testing is performed in patients with hypertrop
182                          Evaluation of FC by exercise testing is rarely performed in MR because littl
183                                              Exercise testing is useful in unmasking QT prolongation
184 latory ECG monitoring, echocardiography, and exercise testing, is recommended.
185 ts; electrophysiological short and prolonged exercise tests; manual muscle testing; and a modified ge
186                   There is new evidence that exercise testing may provide better diagnostic and progn
187 k distance >/= 380 to 440 m, cardiopulmonary exercise test-measured peak oxygen consumption >15 ml/mi
188                              Cardiopulmonary exercise testing measures oxygen uptake at increasing le
189 tween 2004 and 2010 we performed 360 maximal exercise tests (median, 2 tests/patient; range, 1-7) in
190                    Overall, the reporting of exercise-testing methods and data for adults with cancer
191           Therefore, this simple, submaximal exercise test might be useful for assessing physical fit
192       Pre- and post-training cardiopulmonary exercise tests, MRI, and echocardiography, including tis
193 e head-up tilt testing (n=11), low-intensity exercise testing (n=11), and beta blockade (n=10).
194 G, Holter, echocardiography, cardiopulmonary exercise testing, N-terminal pro-brain natriuretic pepti
195 established in 1986-1987, underwent a graded exercise test of aerobic fitness to measure maximal oxyg
196  shown efficacy for ranolazine in increasing exercise testing or reducing anginal episodes or use of
197 ale, 8 female) completed three constant load exercise tests over 4 days.
198     The relationship between cardiopulmonary exercise testing parameters and pregnancy outcome has no
199                              Cardiopulmonary exercise testing parameters are powerful prognosticators
200 latory power and traditional cardiopulmonary exercise testing parameters can be used to predict progn
201  survival prospects based on cardiopulmonary exercise testing parameters in this growing population.
202 hesized that combinations of cardiopulmonary exercise testing parameters may provide optimal prognost
203 mic status, quality of life, cardiopulmonary exercise testing parameters, and biomarker levels.
204 stroke (360 cases) in the cohort of clinical exercise test patients.
205 , peak oxygen consumption by cardiopulmonary exercise testing (pkVO2), New York Heart Association (NY
206                                              Exercise testing pre- and post- training included: (a) s
207 nd heart rate reserve during cardiopulmonary exercise testing predicted risk of early mortality when
208                 Preoperative cardiopulmonary exercise testing predicts surgical outcome and should th
209  VO(2) max was measured using a standardized exercise testing protocol in patients with stage 2 to 4
210  was to determine whether resting LV-GLS and exercise testing provide incremental prognostic utility
211                              Cardiopulmonary exercise testing provides prognostic information in pati
212                              Cardiopulmonary exercise testing provides strong prognostic information
213                                              Exercise testing provoked an abnormal QT response in 42%
214 ure Questionnaire) and cardiac limitation on exercise testing (reduced peak oxygen consumption, 24+/-
215 ed by the DASI correlates with indeterminate exercise test results and is associated with an adverse
216 occurred less (39% vs. 64%, p < 0.0001), and exercise testing results were more often indeterminate (
217 cations, functional class, laboratory tests, exercise testing results, and hemodynamics.
218                                              Exercise tests revealed an increase in exercise capacity
219                          The median baseline exercise test score was 3.0 (range, 0-4), with no differ
220  peak walking time obtained from a treadmill exercise test; secondary outcome measures included daily
221 radoxical myotonia, and an increase in short exercise test sensitivity post-cooling suggest sodium ch
222 ow-technology exercise test, cardiopulmonary exercise testing should be considered.
223                                    The short exercise test showed >/=10% decrement in the compound mu
224          A further 16 subjects, on metabolic exercise testing, showed significant improvement in VO2m
225 p=0.005,)) and fewer minutes completed of an exercise test (sibling odds ratio [OR] 1.59, 95% CI 1.0
226                    In patients with negative exercise tests, specific clinical features are helpful i
227 hough specific morphological valve features, exercise testing, stress imaging, and biomarkers can hel
228 ndomisation assessments with cardiopulmonary exercise testing, symptom questionnaires, and dobutamine
229              In patients with negative short exercise tests, symptomatic eye closure myotonia predict
230 for </=7 days on 2 occasions after a maximal exercise test that was used to calibrate the monitor ind
231 ls need to be identified: these will include exercise testing, the composite end point of time to cli
232                       In patients undergoing exercise testing, the predictive value of PRD was strong
233                              Cardiopulmonary exercise test time increased by 0.48 minute (from 6.79 t
234 s, heart rate recovery after cardiopulmonary exercise testing, time/frequency measures of parasympath
235                              Cardiopulmonary exercise testing, tissue Doppler echocardiography, and M
236 ddition, the 30 athletes performed a maximal exercise test to assess aerobic capacity and anaerobic t
237 tory fitness was assessed using a submaximal exercise test to estimate maximum oxygen consumption adj
238 factor assessment, and incremental treadmill exercise test to evaluate CRF.
239 tic resonance (MR)-augmented cardiopulmonary exercise testing to achieve this goal and assessed child
240       All subjects underwent cardiopulmonary exercise testing to analyze aerobic parameters before an
241 ients underwent preoperative cardiopulmonary exercise testing to determine their anaerobic threshold
242 n </=40%) patients underwent cardiopulmonary exercise testing to evaluate aerobic performance.
243 respiratory fitness (CRF) algorithms without exercise testing to predict the risk for nonfatal cardio
244 n, laboratory testing, echocardiography, and exercise testing) to baseline clinical assessment for pr
245 onal intolerance undergoing upright invasive exercise testing, tricuspid regurgitation (TR) Doppler e
246 esting data alone and reinforce the value of exercise testing using invasive and noninvasive hemodyna
247  predictor of risk for HF among clinical and exercise test variables (hazard ratio, 1.91; 95% confide
248 omogram based on easily obtained pretest and exercise test variables predicted all-cause mortality in
249                           Among clinical and exercise test variables, exercise capacity was the stron
250 iation between HF incidence and clinical and exercise test variables.
251                              Cardiopulmonary exercise testing variables included peak oxygen consumpt
252                           On cardiopulmonary exercise testing, ventilatory response to carbon dioxide
253 timate physical fitness, a submaximal graded exercise test was performed on a bicycle ergometer.
254                                          The exercise test was positive accompanied with nasal discha
255 ise duration on the baseline cardiopulmonary exercise test was the most important predictor of both t
256 ate recovery after a maximal cardiopulmonary exercise test was used as a surrogate for parasympatheti
257 ed to study whether low HR at rest or during exercise testing was a predictor of AF in initially heal
258 y were unavailable, but inability to perform exercise testing was associated with higher incidence of
259                 Preoperative cardiopulmonary exercise testing was included.
260                                              Exercise testing was performed in 115 children able to e
261                         Invasive hemodynamic exercise testing was performed in 46 patients with a rec
262               Using invasive cardiopulmonary exercise testing, we hypothesized that exercise-induced
263      Cardiovascular responses during maximal exercise testing were assessed in the upright position b
264 l associations between clinical outcomes and exercise testing were examined using interaction testing
265 ts of pulmonary-function and cardiopulmonary-exercise testing were generally within normal population
266 int, Seattle Angina Questionnaire score, and exercise testing were not statistically different in bot
267 denosine bronchial challenge and incremental exercise testing were obtained.
268                      MRI and cardiopulmonary exercise testing were performed before and 1 year after
269       Cardiac magnetic resonance imaging and exercise testing were performed prospectively to quantif
270                Parameters of cardiopulmonary exercise testing were recently identified as strong pred
271 proven cardiac limitation by cardiopulmonary exercise testing were studied by standard, tissue Dopple
272                     Subsequent constant load exercise tests were iso-time and iso-work rate, but with
273 with systolic heart failure, cardiopulmonary exercise tests were performed at baseline and approximat
274                                              Exercise tests were scored on an ordinal scale of worst
275 ial predictors, derived from cardiopulmonary exercise testing, were compared with other commonly used
276 nted composite endpoint, anginal status, and exercise testing, were not statistically different betwe
277 pe is an index determined by cardiopulmonary exercise testing, which incorporates pertinent cardiac,
278 dioverter-defibrillator underwent a baseline exercise test while receiving maximally tolerated beta-b
279 ting and a symptom-limited incremental cycle exercise test with arterial blood gas collection.
280  treatment optimization, a progressive cycle exercise test with capillary (c) blood gas collection.
281 s performed a maximal graded cardiopulmonary exercise test with continuous measurements of respirator
282 f 456 subjects performed a 20-minute hypoxia exercise test with continuous recording of ECG and physi
283 ) underwent a symptom-limited supine bicycle exercise test with Doppler echocardiography and respirat
284                              Cardiopulmonary exercise testing with echocardiographic assessment of my
285 underwent pre- and post-fenestration closure exercise testing with expiratory gas analysis.
286 ol subjects (n=30) underwent cardiopulmonary exercise testing with invasive hemodynamic monitoring an
287 erformed maximum incremental cardiopulmonary exercise testing with invasive hemodynamic monitoring on
288                 We performed cardiopulmonary exercise testing with invasive monitoring to measure hem
289 ding tissue tagging and 31P spectroscopy and exercise testing with noninvasive central hemodynamic me
290 underwent high-fidelity invasive hemodynamic exercise testing with simultaneous expired gas analysis
291  and 98 HFpEF subjects underwent hemodynamic exercise testing with simultaneous expired gas analysis
292 cm(2), peak jet velocity >3.5 m/s) underwent exercise testing with simultaneous invasive hemodynamic
293 % on beta-blocker) underwent symptom-limited exercise tests with breath-by-breath expired gas analyse
294 nts with large PFO underwent cardiopulmonary exercise tests with contrast transcranial Doppler, esoph
295 ecutive clinically indicated cardiopulmonary exercise tests with radial and pulmonary arterial cathet
296  supine-cycle maximal-effort cardiopulmonary exercise tests, with measurements of cardiac output and
297 rt disease who had undergone cardiopulmonary exercise testing within 2 years of pregnancy or during t
298               Survival after cardiopulmonary exercise testing without HTx or ventricular assist devic
299 cted (p=0.04), lower maximal cardiopulmonary exercise testing workload (p=0.002), greater proportion
300  component affecting the predictive value of exercise testing, yet current guidelines offer limited a

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top